NEW YORK, July 16, 2026, 06:23 EDT
- UnitedHealth bumped up the lower end of its 2026 adjusted EPS outlook by $1.25 after topping second-quarter estimates by $1.48. Elevance also raised its floor, adding $0.25 following a $1.24 consensus beat.
- UnitedHealth reported a medical cost ratio of 86.7%. That number got a $860 million boost after the insurer’s older claims were marked down. Stripping out that benefit, the MCR is roughly 87.7%, which is still about 0.8 percentage point better than the consensus estimate.
UnitedHealth Group NYSE:UNH bumped its 2026 adjusted earnings forecast to a range of $19.50 to $20.00 a share, moving up after second-quarter adjusted EPS of $6.38 topped analyst picks by $1.48. Shares jumped close to 5% in early premarket. Elevance Health NYSE:ELV closed Wednesday down 8.7% after a smaller boost to guidance, even as it also beat earnings forecasts.
The cleanest read for investors is how much of the quarterly beat ended up in the full-year view. Comparing to the last guidance before results, UnitedHealth put at least 84% of its surprise into its new lower end. Elevance moved about 20% in. This basic measure can help pick out earnings management that’s likely to stick versus one-off quarter items.
This was key since managed-care names bounced back hard after a weak start to the year, so results had more to prove. Baird’s Michael Ha noted expectations for Elevance ran high going into the quarter. A headline beat wasn’t enough, though, when the guidance didn’t shift. That didn’t leave much space for a cautious take.
| Guidance check | UnitedHealth | Elevance |
|---|---|---|
| Q2 adjusted EPS vs estimates | $6.38 vs $4.90 | $7.45 vs $6.21 |
| EPS above consensus | $1.48 | $1.24 |
| Previous Q2 2026 guidance | Above $18.25 | At least $26.75 |
| Updated 2026 view | $19.50-$20.00 | At least $27.00 |
| Smallest raise | $1.25 | $0.25 |
| Increase as pct of Q2 upside | 84% | 20% |
Reuters reported analyst consensus and company filings. Percent figures are from disclosed data based on the most recent pre-Q2 forecasts.
UnitedHealth’s MCR beat consensus by 1.77 points, but $860 million in positive reserve development made up about 0.99 point of that. That happens when earlier claim estimates were too high, the company said, with most of the gain tied to 2026 dates of service. If you add that amount back to costs, MCR comes in close to 87.7%, which is still 0.8 point under consensus.
Elevance flagged another boost this quarter. The company said about $0.80 per share came from non-operating items, which made up around 65% of its $1.24 consensus beat. The care-cost ratio was 0.45 point better than forecasts, but still up 0.8 point year over year. Adjusted operating margin dropped 1.4 points to 3.6%.
Both companies reported lower membership counts, but only UnitedHealth posted a big rebound in insurance margins. UnitedHealthcare had 525,000 fewer members than in March, but its operating margin jumped to 4.6% from 2.4%. Elevance shed 469,000 medical members and saw its Health Benefits margin drop to 2.1% from 3.8%. The business lines aren’t exactly the same, so the direction matters more than the size of the gap.
| Operating check | UnitedHealth | Elevance |
|---|---|---|
| Care-cost ratio / consensus | 86.7% vs 88.47% | 89.7% vs 90.15% |
| Disclosed earnings help | $860 million from claims reserves | About $0.80 per share outside of operating profit |
| Members versus Q1 | Down 525,000 | Down 469,000 |
| Insurance-segment margin, Q2 2026 / Q2 2025 | 4.6% for Q2 2026, 2.4% for Q2 2025 | 2.1% for Q2 2026, 3.8% for Q2 2025 |
UnitedHealth figures are based on UnitedHealthcare members and margin, while Elevance numbers reflect total medical members and Health Benefits margin. Each company has different definitions and business segments.
Chief Executive Stephen Hemsley said the outlook signals “continuing progress in our work to simplify how we operate.” But Chief Financial Officer Wayne DeVeydt warned the quarter was “not a reflection of a trend bending or coming under control.” The company kept revenue guidance at $439 billion. UnitedHealth still expects around 500,000 people to drop its Affordable Care Act plans this year. UnitedHealth Group
Elevance CEO Gail Boudreaux said the Medicaid margin outlook was “appropriately prudent and unchanged from our prior guidance.” The company is sticking with plans for more Medicaid exits over the next 12 to 18 months and will boost spending on medical cost management and member service. It’s still targeting at least 12% adjusted EPS growth in 2027. Reuters
But moving early has downside. UnitedHealth’s help from reserves may not be as big next time, and less membership could mean margin repairs slow revenue. Elevance’s Medicaid strain could get better if state payments increase, but more market exits would shrink its reach. UnitedHealth shares also moved before its 8 a.m. investor call and before trading started on the New York Stock Exchange at 9:30 a.m.
The first look at insurer results gives investors a key question: how much of the quarter’s earnings surprise shows up in annual guidance. UnitedHealth took most of its upside and folded it into its outlook, while Elevance left itself more room, holding back against Medicaid exposure and planning to spend more. That split—more than the headline EPS beats—is driving the big divergence in their stocks.
Related articles: NYSE:UNH
